Disagree
Home Pharmaceutical Grade Pharmaceutical Grade
Diuren 25
Diuren 25 - Pharmaceutical Grade

Diuren 25 - Pharmaceutical Grade

Brand:
Category:
Substance:
Dosage:
25 mg/tab
Package:
20 tablets
Price:
$30.00 - $30.00
See options
Product Overview

Hydrochlorothiazide (HCTZ), a widely prescribed diuretic for hypertension, has been linked to an elevated risk of squamous cell carcinoma (SCC) in kidney transplant recipients undergoing immunosuppressive therapy. A study involving 2,496 transplant patients in France revealed a two-fold increase in SCC risk associated with HCTZ use, attributed to its photosensitizing effects. While no significant link to basal cell carcinoma (BCC) was observed, the study highlights the importance of close monitoring for SCC in transplant recipients prescribed HCTZ, given their heightened vulnerability to skin cancers .

References:

Letellier, T., Leborgne, F., Kerleau, C., Gaultier, A., Dantal, J., & Ville, S., on behalf of the Divat Consortium. (2020) 'Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients', Clinical Journal of the American Society of Nephrology.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Diuren 25 by Pharmaceutical Grade, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
Does Hydrochlorothiazide (HCTZ) increase the risk of basal cell carcinoma (BCC)?
No, Hydrochlorothiazide (HCTZ) was not significantly linked to BCC in the study findings.
References:

Letellier, T., Leborgne, F., Kerleau, C., Gaultier, A., Dantal, J., & Ville, S., on behalf of the Divat Consortium. (2020) 'Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients', Clinical Journal of the American Society of Nephrology.

What population was studied for Hydrochlorothiazide (HCTZ) cancer risk?
Hydrochlorothiazide (HCTZ) was studied in 2,496 transplant recipients, including kidney and pancreas recipients.
References:

Letellier, T., Leborgne, F., Kerleau, C., Gaultier, A., Dantal, J., & Ville, S., on behalf of the Divat Consortium. (2020) 'Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients', Clinical Journal of the American Society of Nephrology.

Why is Hydrochlorothiazide (HCTZ) considered photosensitizing?
Hydrochlorothiazide (HCTZ) can amplify the effects of ultraviolet radiation, increasing the risk of skin cancer like SCC.
References:

Letellier, T., Leborgne, F., Kerleau, C., Gaultier, A., Dantal, J., & Ville, S., on behalf of the Divat Consortium. (2020) 'Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients', Clinical Journal of the American Society of Nephrology.